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Abstract
Annexins are a class of calcium-binding proteins with diverse functions in the regulation of lipid rafts, inflammation,
fibrinolysis, transcriptional programming and ion transport. Within bone, they are well-characterized as components of
mineralizing matrix vesicles, although little else is known as to their function during osteogenesis. We employed shRNA to
generate annexin A2 (AnxA2)- or annexin A5 (AnxA5)-knockdown pre-osteoblasts, and determined whether proliferation or
osteogenic differentiation was altered in knockdown cells, compared to pSiren (Si) controls. We report that DNA content, a
marker of proliferation, was significantly reduced in both AnxA2 and AnxA5 knockdown cells. Alkaline phosphatase
expression and activity were also suppressed in AnxA2- or AnxA5-knockdown after 14 days of culture. The pattern of
osteogenic gene expression was altered in knockdown cells, with Col1a1 expressed more rapidly in knock-down cells,
compared to pSiren. In contrast, Runx2, Ibsp, and Bglap all revealed decreased expression after 14 days of culture. In both
AnxA2- and AnxA5-knockdown, interleukin-induced STAT6 signaling was markedly attenuated compared to pSiren controls.
These data suggest that AnxA2 and AnxA5 can influence bone formation via regulation of osteoprogenitor proliferation,
differentiation, and responsiveness to cytokines in addition to their well-studied function in matrix vesicles.
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Introduction
Annexins comprise a class of calcium-dependent, phospholipid-
binding proteins that are broadly expressed in eukaryotic cells.
They are predominately localized within the cell, where they
mediate such cellular processes as exocytosis and endocytosis,
membrane structure and generation of lipid rafts, formation or
regulation of ion channels, and cytokinesis. A subset of annexins
have extracellular roles, and participate in regulation of inflam-
mation, coagulation and fibrinolysis (reviewed in [1]). More
recently, they have been identified as key mediators in maintaining
endothelial and hematopoietic stem cells within the bone marrow
niche [2,3] and as pivotal regulators of metastasis and adhesion of
prostate cancer cells within bone [4].
Of the 12 Annexins expressed in mammals, Annexins A1, A2,
A4, A5, A6 and A7 are expressed within cells of the chondrogenic
and osteoblastic lineage [5–7]. To date, their function within these
cells has primarily focused upon a putative role in matrix
mineralization. AnxA5 is involved in endochondral ossification,
and is sequentially expressed during vasculogenesis and formation
of the cartilage anlage [8,9]. During embryogenesis and post-natal
skeletal development, AnxA2 and AnxA5 are present in matrix
vesicles secreted by hypertrophic chondrocytes and osteoblasts
[10–15]. Similarly, Annexins A1, A4, and A7 are also found within
matrix vesicles from mineralizing osteoblasts [16]. However, little
data exist as to whether, and when, AnxA2 or AnxA5 exert cell-
autonomous roles in an osteoblast. We have reported that AnxA5
is involved in transducing a biophysical signal–fluid shear stress–
into increases in intracellular calcium and inducing gene
transcription in osteoblasts [17]. With regards to the hematopoi-
etic component of the skeleton, exogenous AnxA2 increases the
formation of human bone marrow multinucleated cells, TRAP-
positive staining, and dentine resorption [18]. Certain of these
effects occur indirectly, as AnxA2 increases pre-osteoclast prolif-
eration by increasing GM-CSF production from bone marrow
stromal cells and activated T cells [19], and promotes ERK1/2-
dependent RANKL secretion from bone marrow stromal cells
[17,20,21]. Gillette and Nielsen-Preiss demonstrated that over-
expression of AnxA2 in human osteosarcoma cells facilitates the
terminal stages of osteogenic differentiation, specifically matrix
mineralization [22], although if AnxA2 exerted a role prior to
mineralization was not examined.
While these data indicate a role for AnxA2 in matrix
mineralization, whether either AnxA2 or AnxA5 have cell-
autonomous effects on processes occurring prior to mineraliza-
tion–proliferation and osteogenic differentiation–remains unex-
amined. In this study, we examined the influence of depletion of
AnxA2 or AnxA5 (AnxA2kd and AnxA5kd, respectively) upon the
proliferation and osteogenic differentiation of the pre-osteoblast
MC3T3-E1 cell line. Reduced expression of AnxA2 or AnxA5
decreased proliferation and altered the dynamic course of
osteogenic differentiation compared to pSiren (Si) control cells.
Mechanistically, AnxA2kd and AnxA5kd each demonstrated
decreased responsiveness to the anti-inflammatory cytokine
interleukin 4 (IL-4), indicating that both AnxA2 and AnxA5 are
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required for maximal responsiveness. In total, these data
demonstrate cell-autonomous roles for both AnxA2 and AnxA5
in proliferation of pre-osteoblasts, matrix maturation and miner-
alization.
Results
Annexin A2 and A5 expression in knockdown cell lines
Stable MC3T3-E1 cell lines deficient in AnxA2 and AnxA5
expression were generated as described in Materials and Methods.
There was a significant reduction (.80%) in AnxA2 mRNA
expression in AnxA2kd cells compared to Si-transfected controls
(Figure 1A), and there was no compensatory change in AnxA5
mRNA in AnxA2kd cells. Similarly, there was a significant
reduction in AnxA5 mRNA in AnxA5kd cells compared to Si
control, and no effect of AnxA5 depletion upon AnxA2 mRNA
expression (Figure 1B). Changes in Annexin expression were also
confirmed at the protein level by western immunoblot (Fig-
ure 1C). Densitometric analysis relative to a-tubulin showed that
AnxA2 protein expression in AnxA2kd was approximately 50% of
Si control (Figure 1D). AnxA5 protein expression was reduced by
approximately 40% in AnxA5kd cells compared to Si control
(Figure 1E).
Proliferation decreases and the dynamics of osteogenic
differentiation are disrupted in Annexin-deficient cells
Having demonstrated significant reduction of AnxA2 and
AnxA5 mRNA and protein, we next examined whether alterations
in AnxA2 or AnxA5 expression influenced pre-osteoblast prolif-
eration. Total DNA content was significantly reduced in AnxA2kd
(14% reduction) and in AnxA5kd (20% reduction) cells, relative to
Si control (Figure 2A). Similar reductions in proliferation were
observed using Calcein-AM (reductions of 29% and 30%;
Figure 2B) and Alamar Blue (18% and 20%; Figure 2C) assays
in AnxA2kd and AnxA5kd, respectively.
Annexins are implicated in matrix mineralization by nature of
their presence in matrix vesicles isolated from osteoblasts and
chondroblasts, although there is no data whether Annexins may
have a role in earlier stages of osteogenic differentiations,
specifically matrix formation or maturation. Thus, we examined
the influence of AnxA2 or AnxA5 reduction upon markers of
osteogenic differentiation. Si control cells showed a dynamic
pattern of gene expression associated with osteogenic differentia-
tion (Col1a1, Runx2, Ibsp, Sp7, Spp1 and Bglap) [23]. For Si
controls, initiation of osteogenesis at 0 days resulted in significant
increases in the osteogenic transcription factors Runx2 and
Osterix (Sp7) after 14 days in culture, and was maintained at 21
days of culture compared to day 0 controls (Figures 3A and B).
A similar time course of Runx2 induction and level of expression
was observed in both AnxA2kd and AnxA5kd cells (Figure 3A),
although Sp7 expression decreased significantly at 21 days in
culture compared to Si controls (Figure 3B). For each cell type,
osteogenic differentiation increased Col1a1 expression, although
induction expression occurred earlier in AnxA2kd and AnxA5kd
cells compared to Si controls (Figure 3C), suggesting that the
ordered process of osteogenic differentiation was subtly altered in
AnxA2kd and AnxA5kd cells. Non-collagenous proteins implicat-
ed in matrix maturation and ordered deposition of hydroxyapa-
tite–bone sialoprotein (Ibsp) and osteocalcin (Bglap or Ocn)–each
revealed altered patterns of expression in knockdown cells
compared to Si controls. Ibsp expression was maximally expressed
after 14 days in culture in Si; AnxA2kd cells demonstrated a
statistically significant increase in Ibsp also at 14 days, although
expression was significantly lower compared to Si, and Ibsp
expression in AnxA5kd cells was not different from 0 days
(Figure 3D). Similarly, Bglap/Ocn expression was attenuated in
AnxA2kd and AnxA5kd cells compared to Si controls after 14 days
in culture (Figure 3E).
Osteogenic differentiation was monitored also by histochemical
staining for alkaline phosphatase, an early marker of osteogenesis,
and mineral deposition into the extracellular matrix. Si control
cells demonstrated a progressive increase in staining intensity with
time in culture that was apparent visually (Figure 4A) and
quantitatively (Figure 4B). In contrast, for both AnxA2kd and
AnxA5kd cells, there was a marked reduction in staining intensity
with time in culture. AnxA2kd cells demonstrated only slight
punctate staining after 21 days in culture. AnxA5kd cells similarly
demonstrated less staining compared to Si controls, although
staining was more pronounced in AnxA5kd compared to
AnxA2kd at both days 14 and 21, indicating that AnxA5kd cells
have an osteogenic potential that is intermediate between Si
controls and AnxA2kd cells. All cell lines deposited significant
quantities of mineral as determined by OsteoImage mineralization
assays at 5 weeks, although Anx2kd cells deposited significantly
less mineral than both Si and Anx5kd cells (Figure 4C).
Figure 1. Characterization of Annexin levels in knockdown
cells. (A) qPCR analysis of AnxA2 expression in pSiren control cells (Si)
and cells stably transfected with either AnxA2 or AnxA5 shRNA
(AnxA2kd and AnxA5kd cells respectively). (B) qPCR analysis of AnxA5
expression in cells stably transfected with either AnxA2 or AnxA5
shRNA. Each bar represents mean transcript normalized to a-tubulin 6
SEM, n= 3–5. **represents statistically significant difference from Si, p,
0.01. (C) Representative western immunoblot for AnxA2, AnxA5 and a-
tubulin protein expression in Si, AnxA2kd and AnxA5kd cells. (D)
Quantitation of AnxA2 protein levels in Si and AnxA2kd cells. (E)
Quantitation of AnxA5 protein levels in Si and AnxA5kd cells. Data are
first normalized to a-tubulin and then to Si control. Each bar represents
mean 6 SEM, n = 6. *represents statistically significant difference from
Si control, p,0.05.
doi:10.1371/journal.pone.0107482.g001
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AnxA2 and AnxA5 are dynamically-expressed during
osteogenic differentiation
Expression of AnxA2 and AnxA5 was monitored in MC3T3
cells cultured in the absence (maintenance media) and presence of
ascorbic acid and b-glycerophosphate (osteogenic), reagents
traditionally used to induce osteogenic differentiation. In mainte-
nance media, AnxA2 expression demonstrated reduction in
expression with increased culture time that reached statistical
significance after 14 or 21 days in culture (Figure 5A, white bars);
similarly, there was no effect of time in culture on AnxA5
expression (Figure 5B, white bars). In contrast, both AnxA2 and
AnxA5 expression increased as a function of time when cells were
cultured in osteogenic media, with AnxA2 demonstrating signif-
icantly increased expression at d14 and d21, and AnxA5 revealing
maximal expression at d14 but then returning toward baseline at
d21. These data indicate that AnxA2 and AnxA5 expression as a
function of time in culture under osteogenic differentiation-
inducing conditions are dynamic.
Reductions in AnxA2 or AnxA5 attenuate IL-4-induced
signaling
Having demonstrated that reducing AnxA2 or AnxA5 attenuate
pre-osteoblast proliferation and alter the timing of osteogenic
differentiation, we began to examine mechanistic explanations for
the observed results. It has been reported that AnxA2 associates
with signal transducer and activator of transcription 6 (STAT6)
and stimulates STAT6 transcriptional activity in prostate cancer
cells [24]. To examine whether reduced AnxA2 or AnxA5
expression influences STAT6 signaling in osteoblastic cells, Si,
AnxA2kd or AnxA5kd cells were transiently transfected with
p4xSTAT6-Luc2P, a plasmid encoding firefly luciferase driven by
four copies of the STAT6 DNA binding site. Cells were
subsequently challenged with 0, 1, or 10 ng/mL IL-4. Si-
transfected cells demonstrated a dose-dependent increase in
Luciferase activity in response to IL-4 (Figure 6). In contrast,
neither AnxA2kd nor AnxA5kd cells demonstrated significant
increases in luciferase activity in response to IL-4, indicating that
reduced AnxA2 or AnxA5 expression compromises STAT6
signaling. There were no significant differences in luciferase
activity between genotypes in the absence of IL-4.
Discussion
Annexins comprise a class of calcium-binding proteins with a
diverse array of intracellular and extracellular functions, including
matrix mineralization in hypertrophic cartilage and bone. Both
AnxA2 and AnxA5 are present in matrix vesicles isolated from
both chondrocytes and osteoblasts, where they are thought to act
as membrane channels to allow Ca2+ influx and hydroxyapatite
crystal formation. Over-expression of AnxA2 correlates with
increased alkaline phosphatase activity and calcium deposition in
osteoblast cultures [22]. However, there are inherent problems
associated with protein overexpression, such as mis-trafficking of
proteins, that could potentially confound the results and conclu-
sions [25]. Further, previous work examined the terminal stage of
osteogenic differentiation–mineralization–without examining
whether other stages, such as proliferation and extracellular
matrix deposition and maturation, and are unable to indicate if
AnxA2 only affects matrix deposition, or multiple stages of
osteogenic differentiation. Thus, we sought whether AnxA2, and
AnxA5, have cell-autonomous roles during multiple stages of
osteogenic differentiation–proliferation, matrix formation and
organization, and matrix mineralization [23].
Pre-osteoblastic MC3T3-E1 cells expressed AnxA2 and AnxA5
at similar levels, as determined by both mRNA and protein
(Figure 1A–C). shRNA techniques stably decreased AnxA2 or
AnxA5 transcript levels by 82% or 88%, respectively, compared to
Si-transfected controls (Figures 1A and 1B), which decreased
AnxA2 or A5 protein expression by 52% or 37%, respectively
(Figures 1C–E); reductions in AnxA2 or AnxA5 elicited no
compensatory change in expression of AnxA2 or A5 at the mRNA
or protein level, consistent with work by Belluoccio et al., who
found no change in AnxA2 or other annexins in compound
Figure 2. Decreased proliferation in AnxA2kd and AnxA5kd
cells. (A) Quantification of DNA concentration 24 hrs after cell seeding.
Bars represent mean DNA concentration (ng/mL sample)6SEM, n = 5–8.
(B) Quantification of Calcein-AM fluorescence 24 hrs after cell seeding.
Bars represent mean calcein fluorescence units 6 SEM, n = 3–8. (C)
Quantification of Alamar blue absorbance 48 hrs after cell seeding. Bars
represent mean optical density 6 SEM, n = 8. *, **represent statistically
significant difference from Si, *p,0.05, **p,0.01.
doi:10.1371/journal.pone.0107482.g002
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AnxA52/2;AnxA62/2 mice [8]. Both AnxA2kd and AnxA5kd
cells have decreased proliferative capacity compared to Si cells
(Figures 2A–C), and suppression of AnxA2 by shRNA similarly
decreases proliferation of adenocarcinoma [26], breast cancer
[27], and multiple myeloma [28] cells.
Osteogenic differentiation occurs with the serial induction of
Runx2 followed by Osterix (Sp7); in all cell types examined, the
pattern of Runx2 expression was similar, suggesting that the
influence of AnxA2 or AnxA5 reductions upon osteogenic
differentiation either is Runx2-independent or involves processes
initiated after induction of Runx2. In contrast, Sp7 was only
transiently expressed in AnxA2kd and AnxA5kd cultures com-
pared to Si, wherein its expression was significantly lower in either
knockdown cell type at 21 days of culture (Figure 3B); these
suggest that both AnxA2 and AnxA5 are required for maximal
induction of Sp7 expression under the course of osteogenic
differentiation. Attenuated expression of Ibsp and Bglap, genes
associated with matrix maturation and proper hydroxyapatite
deposition, was also observed in mutant cells, and the temporal
pattern of Col1a1 expression in AnxA2kd and AnxA5kd cells was
disrupted compared to Si controls. Osteogenic differentiation was
also impaired when examining ALP activity (Figures 4A and
4B) and calcium deposition (Figure 4C). These data indicate that
normal expression of AnxA2 and AnxA5 may be required for the
ordered, sequential processes inherent in osteoblast differentiation.
We observed that AnxA2 and AnxA5 are each dynamically
expressed during the course of osteogenic differentiation. Both
AnxA2 and AnxA5 expression increased significantly after 14 days
in culture (Figures 5A and 5B); AnxA2 remained elevated,
whereas AnxA5 returned to baseline, at 21 days. The observed
changes in osteogenic gene expression (Figures 3A–E) occur at
the same time that AnxA2 and AnxA5 are maximally expressed.
This suggests a causative link between AnxA2 or AnxA5
expression and osteogenesis, which is confirmed by our differen-
tiation studies in AnxA2kd and AnxA5kd cells.
AnxA2kd cells do not phenocopy AnxA5kd cells. While
knockdown of either AnxA2 or AnxA5 decreased DNA content
to the same degree (Figure 2A–C), there exist subtle differences
in the effect of AnxA2 or AnxA5 knockdown upon osteoprogenitor
differentiation. Reducing expression of either Annexin altered
Figure 3. Effects of AnxA2 and AnxA5 knockdown on expression of genes associated with osteogenic differentiation. qPCR analysis of
(A) Runx2, (B) Sp7, (C) Col1a1, (D) Ibsp, and (E) Bglap expression in undifferentiated Si, AnxA2kd and Anx5kd cells (day 0) and in cells cultured in
differentiation medium for 7, 14 and 21 days. Each bar represents mean transcript normalized to a-tubulin6 SEM, n = 3. *, **, ***represent statistically
significant difference from Si at same time point, *p,0.05, **p,0.01, ***p,0.001; + represents statistically significant difference from same genotype
on day 0, p,0.05.
doi:10.1371/journal.pone.0107482.g003
Annexins in Osteoblast Differentiation
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gene expression, but the effects were generally more pronounced
in AnxA2kd cells compared to AnxA5kd cells. For example,
AnxA5kd cells still demonstrated positive staining for ALP activity
after 21 days of culture, whereas positive staining was nearly
absent in AnxA2kd cells (Figure 4A). This was also reflected in
calcium deposition into the extracellular matrix: after 5 weeks of
culture, there was significantly less extracellular calcium in
AnxA2kd cells compared to AnxA5kd, which themselves showed
no difference compared to Si (Figure 4C). Despite attenuated
ALP staining and expression of Ibsp and Bglap, total calcium
deposition was not affected in AnxA5kd cells compared to Si
controls. Because Ibsp and Bglap are involved in matrix
organization, it is possible that the approaches we used to not
fully demonstrate differences in matrix composition between Si
and AnxA5kd cells; further analysis by FT-IR for mineral-matrix
ratio, scanning electron microscopy, or atomic force microscopy
are necessary in order to do so. Nonetheless, data suggest that
AnxA2 and AnxA5 likely exert non-redundant roles in osteogen-
esis.
Mechanistically, the observed results could involve AnxA2 or
AnxA5 functioning as ion channels to regulate cytosolic calcium
levels, critical determinants of progression through the cell cycle
and gene transcription [29,30]. Alternately, Annexins may
regulate gene transcription directly and indirectly. Annexin A4
enhances NF-kB subunit p50 transcriptional activity [31,32], and
Annexin A1 expression positively correlates with NF-kB activity in
breast cancer metastasis [33,34]. In prostate cancer cells, AnxA2
physically interacts with STAT6 to stabilize cytosolic levels of
phosphorylated STAT6 and promote its nuclear localization [24].
Transfection of cells with a STAT6-reporter plasmid demonstrat-
ed that IL-4-induced signaling is attenuated in AnxA2kd or
AnxA5kd cells compared to Si controls (Figure 6). T helper
lymphocytes (Th2 cells) secrete IL-4, -5, -10, and -13, which are
generally anti-inflammatory by inhibiting the activity of cytokines
secreted from Th1 cells, such as IL-1, -2, -6, and -12 [35]. IL-4
stimulates proliferation and mineralization by enhancing hydroxy-
proline accumulation, calcium deposition, and osteocalcin secre-
tion [36,37]; because we observed attenuated response to IL-4 and
osteogenic differentiation in AnxA2kd and AnxA5kd cells, it is
possible that AnxA2 and AnxA5 function as regulators of
transcription in osteoblastic cells. Indeed, Belluoccio et al. reported
significant alteration in the transcriptome of compound AnxA52/
2;AnxA62/2, wherein 56% of differentially-regulated genes
(defined by 3-fold difference compared to control) were related
to cell survival, involving cell motility, apoptosis, cell cycle, cell
proliferation and differentiation and tumor suppressor/survival
[8].
Direct regulation of osteogenesis may also involve the capacity
of AnxA2 to bind and sequester Sclerostin, an inhibitor of the Wnt
signaling pathway [38]. Manipulation of Wnt signaling through
altered expression of antagonists or the Wnt co-receptor Lrp5
exerts robust effects upon bone formation and homeostasis [39–
41], and biophysical factors that influence Sclerostin expression in
mature osteoblasts also regulate AnxA2 expression [42,43],
although whether this is correlative or causative requires further
study. Nonetheless, we have provided the first evidence that
AnxA2 and AnxA5 are involved in pre-osteoblast proliferation, the
timing and magnitude of osteogenic gene expression, matrix
maturation, and responsiveness to anti-inflammatory cytokines.
These results provide the foundation to consider novel multifac-
eted roles for AnxA2 and AnxA5 in osteogenesis.
Materials and Methods
Cell culture
MC3T3-E1 (clone 14; ATCC) osteoblastic cells were stably-
transfected with pSIREN vector (Si; Clontech) with or without
Figure 4. Effects of AnxA2 and AnxA5 knockdown on ALP and hydroxyapatite. (A) ALP activity staining in MC3T3-E1 cells (MC3T3), Si,
AnxA2kd and AnxA5kd cells after culture in osteogenic differentiation media for 7, 14 and 21 days, representative images from n=3 biological
replicates. (B) Quantitation of ALP staining intensity. Bars represent mean integrated signal intensity6 SEM, n = 3. + represents statistically significant
difference from same genotype on day 0, p,0.05. **represented statistically significant different from Si at the same day, p,0.01. (C) OsteoImage
staining for hydroxyapatite in Si, AnxA2kd and Anx5kd cells cultured with differentiation media for 5 weeks. Each bar represents OsteoImage
fluorescence normalized to PI 6 SEM, n = 3. ***represents statistically significant difference from maintenance media within the same genotype,
***p,0.001; + represents statistically different from Si in same media composition, p,0.01.
doi:10.1371/journal.pone.0107482.g004
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siRNA targeting AnxA2 or AnxA5. Generation of AnxA2- and
AnxA5-knockdown cells is described below. Cells were maintained
under 95% ambient air, 5% CO2 in humidified incubators.
Medium was Minimal Essential Medium, alpha modification
(Invitrogen), supplemented with 10% FBS (Invitrogen) and 1%
penicillin-streptomycin. Puromycin (2 mg/ml) was added to the
media to maintain selection of the cells. Cells were routinely sub-
cultured with 0.05% trypsin and except where noted, cells were
seeded at a density of 3,000/cm2, and studies performed the
following day. For osteogenic differentiation studies growth
medium was supplemented with 50 mg/mL ascorbic acid (Sigma)
and 5 mM b-glycerophosphate (Sigma).
Generation of AnxA2 and AnxA5 knockdown cells
AnxA2 knockdown cells (AnxA2kd) were generated as previ-
ously reported [44]. AnxA5 knockdown cells (AnxA5kd) were
created using the pSIREN vector (Clontech) containing AnxA5
shRNA (target sequence from Qiagen siRNA-SI00899101).
shRNA was ligated into pSIREN, transformed into DH5-alpha
competent cells (Invitrogen), and amplified in Luria broth
containing ampicillin (50 mg/mL). Before transfection, the plas-
mids were sequenced to confirm the presence of the shRNA (data
not shown). Plasmids (2–4 mg) were transfected into MC3T3-E1
cells using Clonfectin (Clontech) and three days later the cells were
placed in media containing puromycin (2 mg/ml) for selection.
After one week, surviving colonies were placed into 48-well plates
and maintained in culture. Three weeks later, cells were tested for
AnxA5 expression by western immunoblot.
Western immunoblot analysis
Cells were washed with phosphate buffered saline (PBS) and
whole cell protein lysates were collected in RIPA buffer (15 mM
Tris-HCl, pH 7.6, 1% Igepal CA-630, 0.5% sodium deoxycholate,
and 0.1% SDS), supplemented with a protease inhibitor cocktail
(Pierce-ThermoFisher). Samples were separated on 10% Bis-Tris
gels (Invitrogen), transferred onto 0.2 mM nitrocellulose mem-
branes, and blocked in 5% non-fat milk in Tris-buffered saline.
Proteins were detected with antibodies directed against AnxA2
(1:1000, Santa Cruz), Anx A5 (1:1000, Santa Cruz), and a-tubulin
(1:1000, Cell Signaling). A secondary goat anti-rabbit antibody
linked to horseradish peroxidase (1:1000, Jackson ImmunoRe-
search) was used before developing in ECL (Invitrogen).
Quantitative PCR
One mg of total RNA was reverse-transcribed with Superscript
II Reverse Transcription Kit (Invitrogen) and qtPCR was
performed using primer and TaqMan probe sets (Applied
Biosystems, Foster City, CA) and QuantiFast Probe PCR kit
(Qiagen, Valencia, CA) on a Mastercycler realplex2 (Eppendorf,
Westbury, NY). Amplification conditions were 95uC for 3 min,
followed by 40 cycles at 95uC for 3 s and 60uC for 30 s. Taqman
Primer and probe sets AnxA2, AnxA5, Col1a1, Ibsp, Runx2, Sp7,
Bglap, and TubA were purchased from Applied Biosystems.
Quantitative PCR results were normalized to TubA transcript
level for MC3T3-E1 cells to Si controls to obtain 22DDCt [45].
ALP activity staining and quantitation
Cells were seeded in 35-mm plates and grown for 7, 14 and 21
days in osteogenic differentiation medium and stained with an
ALP activity staining kit (Sigma) according to manufacturer’s
instructions. Briefly, cells were washed with pre-warmed PBS
(37uC) and fixed with citrate-acetone-formaldehyde solution. After
fixing, cells were washed with filtered de-ionized water, incubated
Figure 5. Effects of osteogenic differentiation on expression of
AnxA2 and AnxA5. qPCR analysis of (A) AnxA2 or (B) AnxA5
expression in undifferentiated Si cells at day 0 and in cells cultured in
maintenance or osteogenic media 7, 14 and 21 days. Each bar
represents mean transcript normalized to a-tubulin 6 SEM, n = 3–5. *,
**represent statistically significant difference from maintenance control
at same time point, *p,0.05, **p,0.01; + represents statistically
different from same media composition on day 0, p,0.05.
doi:10.1371/journal.pone.0107482.g005
Figure 6. IL-4-induced STAT6 signaling in parental and mutant
cells. Si, AnxA2kd, or AnxA5kd cells were transiently transfected with
p4xSTAT6-Luc2P and treated with 0, 1, or 10 ng/mL IL-4 for 24 hours,
after which Luciferase activity was measured. Each bar represents mean
Luciferase activity 6 SEM normalized to vehicle control, n = 3. *,
***represent statistically significant difference from Si control, *p,0.05,
**p,0.01; + represents statistically significant difference compared to
Siren at same IL-4 concentration, p,0.001.
doi:10.1371/journal.pone.0107482.g006
Annexins in Osteoblast Differentiation
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with alkaline dye mixture for 15 min, washed and then allowed to
air-dry. Digital images were acquired using a flatbed scanner.
Integrated density was calculated as the area of the image
multiplied by the mean gray value, when white was defined as 0
and black as 255.
Proliferation assays
Cells were seeded at 5,000 cells/well in 96-well plates and 3
different proliferation assays were performed: 1) 25 hrs after
seeding, cells were washed with PBS, lysed with water, and a
NanoDrop (Thermo-Fisher) was used to measure DNA concen-
tration; 2) Calcein-AM (2 mg/ml; Invitrogen) was added to the
cells in Earle’s Balanced Saline Solution 24 hrs after seeding,
incubated for 30 min at 37uC, then fluorescence was read at 485/
530 nm (Biotek); 3) Alamar blue (Invitrogen) was added directly to
the cells 24 hrs after seeding. Cells were maintained in culture for
a further 24 hrs after which absorbance was read at 570 nm.
OsteoImage Mineralization Assay
Cells were in 96-well plates, and osteogenic differentiation
media was added the following day. After 5 weeks in differenti-
ation media, the cells were washed with PBS, fixed with MeOH
and incubated with fluorescent OsteoImage staining reagent,
which binds to hydroxyapatite, per the manufacturer’s protocol
(Lonza Walkersville, Inc.). Fluorescence was read at 485/530 nm
for OsteoImage staining. Propidium iodide (5 mM) was added for
60 min and the plate was quantitated at 530/620 nm. Osteo-
Image values were normalized to propidium iodide values.
STAT6 signaling assay
Si, AnxA2kd or AnxA5kd cells were seeded at a density of
20,000 cells/well in 48-well plates, and the next day were and
transfected with a cocktail composed of (per well) 1.2 mL X-
tremeGENE HP (Roche Applied Science), 250 ng 4xSTAT6-
Luc2P (plasmid 35554, kindly provided by Dr. Axel Nohturfft
through Addgene), and 100 ng of pRL-TK (Promega). Twenty-
four hours later, cells were treated with 0, 1, or 10 ng/mL IL-4
(PeproTech) in growth medium; after 24 hours of treatment, wells
were washed in PBS, scraped and collected in passive-lysis buffer,
and analyzed using Dual-Luciferase Reporter System (Promega)
and TD-20/20 luminometer (Turner Systems).
Statistical analysis
One- or two-way ANOVA was performed on proliferation,
PCR, western blot quantitation and OsteoImage data. Individual
significance was determined by Tukey’s multiple comparison test.
Statistical significance was considered at p,0.05 for all tests
performed.
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